The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Allergan Inc

NYSE: AGN
Last

(U.S.) $213.89

Today's change-0.11 -0.05%
Updated November 28 1:06 PM EST. Delayed by at least 15 minutes.
 

Allergan Inc

NYSE: AGN
Last

(U.S.) $213.89

Today's change-0.11 -0.05%
Updated November 28 1:06 PM EST. Delayed by at least 15 minutes.

Allergan Inc down slightly

Allergan Inc closed down just (U.S.)$0.11 Friday to (U.S.)$213.89. Over the last five days, shares have gained 2.30% and 92.55% year to date. Shares have outperformed the S&P 500 by 105.49% during the last year.

Key company metrics

  • Open(U.S.) $214.09
  • Previous close(U.S.) $214.00
  • High(U.S.) $214.64
  • Low(U.S.) $213.56
  • Bid / Ask-- / --
  • YTD % change+92.55%
  • Volume869,813
  • Average volume (10-day)6,691,600
  • Average volume (1-month)4,141,086
  • Average volume (3-month)2,929,500
  • 52-week range(U.S.) $94.98 to (U.S.) $214.64
  • Beta0.76
  • Trailing P/E49.85×
  • P/E 1 year forward33.96×
  • Forward PEG1.61×
  • Indicated annual dividend(U.S.) $0.20
  • Dividend yield0.09%
  • Trailing EPS(U.S.) $4.29
Updated November 28 1:06 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.58%

Based on its net profit margin of 18.58%, Allergan Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,8171,8641,6461,684
Total other revenue--------
Total revenue1,8171,8641,6461,684
Gross profit1,6111,6421,4421,480
Total cost of revenue207222205205
Total operating expense1,4241,2561,2641,230
Selling / general / administrative715719659619
Research & development289289349262
Depreciation / amortization29282828
Interest expense (income), net operating--------
Unusual expense (income)186-224116
Other operating expenses, total--------
Operating income393608382455
Interest income (expense), net non-operating-18-20-16-18
Gain (loss) on sale of assets--------
Other--------
Income before tax419574362441
Income after tax313418259313
Income tax, total106156103128
Net income313417257313
Total adjustments to net income--------
Net income before extra. items312417258313
Minority interest-1-1-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items312417258313
Inc. avail. to common incl. extra. items313417257313
Diluted net income313417257313
Dilution adjustment----0--
Diluted weighted average shares303304304302
Diluted EPS excluding extraordinary itemsvalue per share1.031.370.851.04
Dividends per sharevalue per share0.050.050.050.05
Diluted normalized EPSvalue per share1.491.370.911.31